Nevirapine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study

A rapid, sensitive and specific method to quantify nevirapine in human plasma using dibenzepine as the internal standard (IS) was developed and validated. The method employed a liquid-liquid extraction. The analyte and the IS were chromatographed on a C(18) analytical column, (150 x 4.6 mm i.d. 4 microm) and analyzed by tandem mass spectrometry in the multiple reaction monitoring mode. The method had a chromatographic run time of 5.0 min and a linear calibration curve over the range 10-5000 ng ml(-1) (r(2) > 0.9970). The between-run precision, based on the relative standard deviation for replicate quality controls was 1.3% (30 ng ml(-1)), 2.8% (300 ng ml(-1)) and 3.6% (3000 ng ml(-1)). The between-run accuracy was 4.0, 7.0 and 6.2% for the above-mentioned concentrations, respectively. This method was employed in a bioequivalence study of two nevirapine tablet formulations (Nevirapina from Far-Manguinhos, Brazil, as a test formulation, and Viramune from Boehringer Ingelheim do Brasil Química e Farmacêutica, as a reference formulation) in 25 healthy volunteers of both sexes who received a single 200 mg dose of each formulation. The study was conducted using an open, randomized, two-period crossover design with a 3 week washout interval. The 90% confidence interval (CI) of the individual ratio geometric mean for Nevirapina/Viramune was 96.4-104.5% for AUC((0-last)), 91.4-105.1% for AUC((0-infinity)) and 95.3-111.6% for C(max) (AUC = area under the curve; C(max) = peak plasma concentration). Since both 90% CI for AUC((0-last)) and AUC((0-infinity)) and C(max) were included in the 80-125% interval proposed by the US Food and Drug Administration, Nevirapina was considered bioequivalent to Viramune according to both the rate and extent of absorption.     

Relationships between structure,ionization profile and sensitivity of exogenous anabolic steroids under electrospray ionization and analysis in human urine using liquid chromatography–tandem mass spectrometry

The relationships between the ionization profile, sensitivity, and structures of 64 exogenous anabolic steroids (groups I–IV) was investigated under electrospray ionization (ESI) conditions. The target analytes were ionized as [M + H]⁺ or [M + H–nH₂O]⁺ in the positive mode, and these ions were used as precursor ions for selected reaction monitoring analysis. The collision energy and Q3 ions were optimized based on the sensitivity and selectivity. The limits of detection (LODs) were 0.05–20 ng/mL for the 64 steroids. The LODs for 38 compounds, 14 compounds and 12 compounds were in the range of 0.05–1, 2–5 and 10–20 ng/mL, respectively. Steroids including the conjugated keto‐functional group at C3 showed good proton affinity and stability, and generated the [M + H]⁺ ion as the most abundant precursor ion. In addition, the LODs of steroids using the [M + H]⁺ ion as the precursor ion were mostly distributed at low concentrations. In contrast, steroids containing conjugated/unconjugated hydroxyl functional groups at C3 generated [M + H ? H₂O]⁺ or [M + H ? 2H₂O]⁺ ions, and these steroids showed relatively high LODs owing to poor stability and multiple ion formation. An LC‐MS/MS method based on the present ionization profile was developed and validated for the determination of 78 steroids (groups I–V) in human urine. Copyright © 2015 John Wiley & Sons, Ltd.     

液相色谱-串联质谱法测定头发中10种蛋白同化激素

建立了同时测定头发中10种蛋白同化激素液相色谱-串联质谱(LC/MS/MS)分析方法。头发样品经NaOH消解、戊烷液液提取后,用反相液相色谱分离,电喷雾正离子源进行离子化,用多反应监测方式(MRM)对这10种蛋白同化激素的母离子及子离子进行监测,三重四极杆质谱测定。10种蛋白同化激素的检出限为1~20ng/g;相对标准偏差(RSD)为1.72%~13.77%;回收率为38.20%~110.38%;线性回归系数(R2)为0.9958~0.9999。本方法简便快速、灵敏度高、专属性强,可满足在兴奋剂检测或毒物分析中对毛发中蛋白同化激素测定的要求。     

猪血浆中33种类固醇激素的高效液相色谱-串联质谱测定

建立了猪血浆中雌激素、雄激素、皮质激素、孕激素以及部分违禁添加激素的高效液相色谱-串联质谱（HPLC-MS/MS）检测方法。以叔丁基甲醚为提取溶剂,涡旋振荡进行提取,采用Xselect-C18和Extend-C18（3.5μm,2.1mm×100mm）色谱柱进行目标物分离,外标法定量。结果表明,33种类固醇激素在其线性浓度范围内线性关系良好,相关系数均大于0.99;在3个不同浓度下的加标回收率为50.9%~119.5%,相对标准偏差为2.3%~9.8%,定量下限（LOQ）为0.05~40.00ng/mL。采用所建立方法对北京某大型养猪场所采样品进行检测,共有10种激素被测出。该方法操作简单、灵敏度高、重现性好,可满足对猪血浆中类固醇激素的检测和验证要求。     

超高效液相色谱–串联质谱法测定饮用水中微囊藻毒素

建立饮用水中微囊藻毒素(MC–RR,MC–LR)的超高效液相色谱–串联质谱检测方法。样品经PVDF针式过滤头过滤后直接进样,采用喷雾正离子源(ESI~+)和多重反应监测模式(MRM)测定。MC–RR的质量浓度在0.02~10.00μg/L范围内与色谱峰面积呈良好的线性,线性相关系数r~2=0.998 9,检出限为0.096μg/L,测定结果的相对标准偏差为6.6%~9.1%(n=7),加标回收率为99.0%~103.0%。MC–LR的质量浓度在0.1~20μg/L范围内与色谱峰面积呈良好的线性,线性相关系数r~2=0.999 2,检出限为0.188μg/L,测定结果的相对标准偏差为4.3%~10.0%(n=7),加标回收率为93.0%~114.0%。该方法灵敏度高、重现性好,可用于饮用水中微囊藻毒素的检测。     

高效液相色谱串联质谱法测定血清中内美通

研究了高效液相色谱串联质谱联用测定人血清中内美通的方法。用乙醚提取血清中的内美通,米非斯酮做内标,电喷雾离子化,选择内美勇母、子离子对m/z309-m/z241;内标的母、子离对对m/z430-m/z372;串联质谱采用多反应扫描监测方法,定量测定人血清的内美通。该方法测定速度快,灵敏度高,选择性好。方法的标准曲线线性范围3.5-177μg/L（r^2=-0.999);检出限0.8μg/L;进行6次平行测定,日间RSD=2.3%-13.7%,RD=4.8%-3.0%;日内RSD=5.5%-14.8%,RE=3.1%-6.7%;回收率内美通是91.0%,内标米非斯酮是90.6%。4min完成一个样品测定。     

高效液相色谱－串联质谱法检测配合饲料中11种蛋白同化激素含量

建立了快速分析配合饲料中睾酮、甲基睾酮、勃地龙、美雄酮、雄烯二酮、脱氢异雄酮、诺龙、丙酸诺龙、司坦唑醇、美伦孕酮、黄体酮11种蛋白同化激素的高效液相色谱－串联质谱（HPLC－MS/MS）法。样品采用乙腈提取,经PSA粉净化后上机测定。采用PhenomenexC₁₈（100mm×2.1mm,2.6μm）色谱柱,以0.01%甲酸溶液－乙腈作为流动相进行梯度洗脱,电喷雾离子源正离子模式检测,同位素内标法定量。结果表明,11种蛋白同化激素的线性范围为1~100ng/mL,相关系数均为0.999,检出限为20μg/kg,定量下限为50μg/kg。50、250、500μg/kg加标水平下,鸡配合饲料中各蛋白同化激素的回收率为94.5%~111%,日内相对标准偏差（RSD）和日间RSD均不大于13%;猪配合饲料中各蛋白同化激素的回收率为90.1%~109%,日内RSD不大于9.0%,日间RSD不大于8.8%。实际样品中检出睾酮和勃地龙,含量分别为9.09~14.68mg/kg和1.22~1.84mg/kg。该方法可为饲料中蛋白同化激素的滥用监管提供技术支撑。     

反相高效液相色谱／质谱法同时测定鸡肉中5种喹诺酮药物残留

采用反相高效液相色谱／四级杆串联质谱（RP-HPLC／MS／MS）同时测定鸡肉中的5种喹诺酮药物（quinolones，QNs）。均质后的鸡肉样品采用磷酸盐缓冲溶液和乙腈的混和溶液提取。提取液经正己烷液-液分配（LLP）去除脂肪后，用C18固相萃取（SPE）柱净化，氨化甲醇洗脱，洗脱液用氮气吹干，流动相定容后，分析物采用LC／MS／MS电喷雾电离（ESI），正离子，多反应监测（MRM）模式检测，外标法定量。在添加浓度2．5～10μg/kg范围内，5种QNs的回收率在79．8％～95．1％之间；相对标准偏差（RSD）均小于11．7％。环丙沙星、丹诺沙星、恩诺沙星检出限（LOD）为0．5μg／kg，沙托沙星为1．0μg／kg，氟甲喹为0．1μg／kg。     

Feasibility of a liquid-phase microextraction sample clean-up and liquid chromatographic/mass spectrometric screening method for selected anabolic steroid glucuronides in biological samples

Anabolic androgenic steroids (AAS) are metabolized extensively in the human body, resulting mainly in the formation of glucuronide conjugates. Current detection methods for AAS are based on gas chromatographic/mass spectrometric (GC/MS) analysis of the hydrolyzed steroid aglycones. These analyses require laborious sample preparation steps and are therefore time consuming. Our interest was to develop a rapid and straightforward method for intact steroid glucuronides in biological samples, using liquid-phase microextraction (LPME) sample clean-up and concentration method combined with liquid chromatographic/tandem mass spectrometric (LC/MS/MS) analysis. The applicability of LPME was optimized for 13 steroid glucuronides, and compared with conventional liquid-liquid extraction (LLE) and solid-phase extraction (SPE) procedures. An LC/MS/MS method was developed for the quantitative detection of AAS glucuronides, using a deuterium-labeled steroid glucuronide as the internal standard. LPME, owing to its high specificity, was shown to be better suited than conventional LLE and SPE for the clean-up of urinary AAS glucuronides. The LPME/LC/MS/MS method was fast and reliable, offering acceptable reproducibility and linearity with detection limits in the range 2-20 ng ml(-1) for most of the selected AAS glucuronides. The method was successfully applied to in vitro metabolic studies, and also tested with an authentic forensic urine sample. For a urine matrix the method still has some unsolved problems with specificity, which should be overcome before the method can be reliably used for doping analysis, but still offering additional and complementary data for current GC/MS analyses.     

液相色谱-质谱法对饮用水中六价铬的测定

建立了液相色谱分离、电喷雾质谱测定饮用水中六价铬的方法。水样经微孔滤膜过滤后直接进样,以乙腈-1.5mmol/L四丁基氢氧化铵水溶液为流动相,XterraTMMSC18色谱柱分离六价铬,使用单四极杆质谱,选择离子模式检测,监测离子为m/z118、117、101、85,其中117为定量离子。Cr(Ⅵ)的线性范围为1.0¹00.0μg/L,方法定量下限为1μg/L。在空白水样中分别添加1.0、2.0、10.0μg/L的六价铬,测得平均回收率(n=5)依次为91%、94%、97%,相对标准偏差分别为12.2%、7.4%、3.5%。测定了42个饮用水样品,其中17批检出六价铬,检出量为1.2¹5.4μg/L。     

高效液相色谱-串联质谱联用技术测定环境水样中的全氟化合物

采用HPLC-ESI-MS/MS联用技术,以C18反相柱为分析柱,以甲醇、醋酸铵为淋洗液,10min即可分离全氟庚酸(PFHeA)、全氟辛酸(PFOA)、全氟辛烷磺酸(PFOS)、全氟壬酸(PFNA)和全氟癸酸(PFDeA)5种全氟化合物。样品溶液500mL经RP柱离线浓缩、2mL甲醇洗脱、水定容至5mL后,50μL进样分析。以363/319、412.9/368.9、498.9/80、462.9/419和512.8/469离子对分别对PFHeA,PFOA,PFOS,PFNA和PFDeA进行监控和定量检测。线性范围在0.5~20ng/L之间(r≥0.9944),5种物质的检出限依次为0.10、0.15、0.11、0.11和0.18ng/L。该方法已成功运用于4种环境水样的测定,4ng/L的加标回收结果在52.6%~117.5%之间。     

A sensitive and selective HPLC–MS3 method for therapeutic drug monitoring of meropenem and its validation by comparison with HPLC–MS2 methods

Meropenem, a representative β-lactam antibiotic, is widely used to treat complicated and serious infections. Therefore, it is of great significance to monitor the plasma drug concentration for individualized antimicrobial therapy. This study first describes the development and validation of high-performance liquid chromatography–tandem mass spectrometry cubed method for monitoring meropenem in human plasma. Protein precipitation with methanol and a chromatographic analysis time of 7 min make this method simple and of high throughput. Meropenem was extracted from human plasma with recoveries >94.1%. Calibration curves were linear (R² > 0.995) in the concentration range of 0.5–50 μg/mL. Overall accuracy and precision did not exceed 8.0% as well as no significant matrix effect was observed. The novelty of this method is that the triple-stage mass spectrometry technology improves the selectivity and sensitivity. A comparison of the presented method and traditional liquid chromatography–tandem mass spectrometry method was assessed in 44 patients treated with meropenem and Passing–Bablok regression coefficients and Bland–Altman plots showed that no significant difference between the two methods. So the triple-stage mass spectrometry method developed in this study is appropriate and practical for the monitor of meropenem in the daily clinical laboratory practice.